You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Portable Neutron Spectrometer
SBC: RADIATION DETECTION TECHNOLOGIES, INC. Topic: DTRA133003ABSTRACT: Proposed is the development of an advanced solid state neutron spectrometer (NeuKopis) with directional resolve, building from prototype instruments that have demonstrated the art-of-the-possible. The intrinsic neutron detection efficiency of the refined BENEFITS: Low power, solid state, compact, rugged, economical, portable
SBIR Phase I 2014 Department of DefenseDefense Threat Reduction Agency -
A Generic Cross-Platform Perception API for Unmanned Vehicles
SBC: Honeybee Robotics, Ltd. Topic: OSD13HS4ABSTRACT: Autonomous vehicles lack a standardized mechanism for seamless cross-platform sharing of testing frameworks and evaluations of basic tasks. The ability to execute common tests on various hardware platforms is essential in order to be able to e
SBIR Phase I 2014 Department of DefenseDefense Threat Reduction Agency -
A Novel Small Molecule Therapeutic for Alcoholic Chronic Pancreatitis
SBC: Angion Biomedica Corp. Topic: NIAAADESCRIPTION (provided by applicant): Chronic Pancreatitis (CP) is characterized by continuous or recurrent inflammation of the pancreas that leads to permanent destruction of the pancreas resulting in exocrine and endocrine insufficiency. CP is a common disorder associated with significant morbidity and mortality with an incidence of 8.2 and a prevalence of 27.4 per 100 000 population. The etiolog ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A turn-key optogenetics and electrophysiology measurement system
SBC: Pinnacle Technology, Inc. Topic: NIAABSTRACT Age-related sleep problems such as advanced sleep phase disorder (ASPD) are estimated to affect at least 1% of middle-aged adults and increase in prevalence with age. While the detrimental effects of sleep disruption with aging are well characterized, detailed insights into the molecular and physiological mechanisms underlying these sleep changes are greatly lacking. Optogenetics harnesse ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
PRECLINICAL TESTING OF HUMAN GHRELIN AND GROWTH HORMONE FOR SEPSIS IN THE ELDLY
SBC: THERASOURCE, LLC Topic: NIADESCRIPTION (provided by applicant): The ultimate goal of our proposal is to develop a novel therapeutic approach that will save lives of aged septic patients. Sepsis is the most common cause of death in the non-cardiac intensive care units (ICU). It is particularly a serious problem in the geriatric population. The elderly (e 65 years of age) accounts for 12% of the US population but 65% of sepsi ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development, Production and Testing of VLP based Respiratory Syncytial Virus (RSV
SBC: TECHNOVAX INC Topic: NIAIDDESCRIPTION (provided by applicant): The goal of this proposal is to develop a safe and efficacious virus-like particle (VLP) based-respiratory syncytial virus (RSV) vaccine to prevent the disease caused by this pathogen. The respiratory illnesses provokedby RSV in infants, children and the elderly are of global economical and public health impact. A recent worldwide estimate [5] indicates that ov ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Therapeutic for Radiation Induced Lung Injury
SBC: Angion Biomedica Corp. Topic: NIAIDDESCRIPTION (provided by applicant): Nuclear accidents and terrorism present a serious threat for causing mass-casualty scenarios. In radiation events, many people receive non-uniform whole-body or partial-body irradiation. The risk of exposure to ionizingradiation due to terrorist activities could result in acute injury as well as long-term adverse health effects in thousands of people. The lung ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Large Scale Synthesis of the Next Generation Synthetic Saponin Adjuvant TiterQuil
SBC: ADJUVANCE TECHNOLOGIES INC. Topic: NIAIDDESCRIPTION (provided by applicant): Antitumor and anti-infectious disease vaccines require adjuvants in order to obtain optimal immunogenicity and therapeutic and protective efficacy. QS-21 is a natural saponin fraction that significantly out-performs other adjuvants in eliciting productive antibody and T-cell responses. It has remained the adjuvant of choice and has proven it's potency as i ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Discovery of inhibitors of the metabolic oncogene 3-phosphoglycerate dehydrogenas
SBC: Kadmon Corporation, LLC Topic: NCIDESCRIPTION (provided by applicant): Many profound metabolic alterations have been described in solid tumors which present attractive therapeutic targets. One recently described metabolic oncogene is 3- phosphoglycerate dehydrogenase (PHGDH), the rate-limiting step in the pathway synthesizing serine and glycine for proteins, lipids, folate and nucleotide metabolism. The PHGDH gene is amplified a ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Deimmunized TLR5 Agonist for Anticancer Therapy
SBC: BUFFALO BIOLABS, LLC Topic: NCIABSTRACT: Radiotherapy is widely used to treat various types of cancer; however, its effectiveness is frequently limited by severe adverse effects resulting from radiation-induced damage to normal tissues in the tumor environment. Due to the scale of thisproblem and the current lack of safe and effective countermeasures against radiation toxicity, development of such agents is of broad significanc ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health